E629-0194 Screening compound: N-[3-(4-benzylpiperidin-1-yl)propyl]-2-[2-(thiophen-2-yl)-1H-indol-1-yl]acetamide

E629-0194 Screening compound: N-[3-(4-benzylpiperidin-1-yl)propyl]-2-[2-(thiophen-2-yl)-1H-indol-1-yl]acetamide
E629-0194 Screening compound: N-[3-(4-benzylpiperidin-1-yl)propyl]-2-[2-(thiophen-2-yl)-1H-indol-1-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E629-0194
N-[3-(4-benzylpiperidin-1-yl)propyl]-2-[2-(thiophen-2-yl)-1H-indol-1-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E629-0194

Molecular Formula

C29H33N3OS (C29 H33 N3 OS)

Compound Name

N-[3-(4-benzylpiperidin-1-yl)propyl]-2-[2-(thiophen-2-yl)-1H-indol-1-yl]acetamide

IUPAC name

N-[3-(4-benzylpiperidin-1-yl)propyl]-2-[2-(thiophen-2-yl)-1H-indol-1-yl]acetamide

SMILES

O=C(Cn(c(-c1cccs1)c1)c2c1cccc2)NCCCN1CCC(Cc2ccccc2)CC1

InChI

InChI=1S/C29H33N3OS/c33-29(22-32-26-11-5-4-10-25(26)21-27(32)28-12-6-19-34-28)30-15-7-16-31-17-13-24(14-18-31)20-23-8-2-1-3-9-23/h1-6,8-12,19,21,24H,7,13-18,20,22H2,(H,30,33)

InChI Key

VPVWGFJGQBZPHZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27600642

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

471.67

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

6.008

Distribution Coefficient, logD

3.916

Water Solubility, LogSw

-6.71

Polar Surface Area

29.463

Acid Dissociation Constant (pKa)

15.31

Base Dissociation Constant (pKb)

9.49

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.50

E629-0194 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Nervous system
Targets:
  • GPCR
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E629-0194 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E629-0194?
Check Price and Availability of E629-0194, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E629-0194 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E629-0194
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E629-0194
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E629-0194 available by request